+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis



Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis



Biology of Reproduction 59(4): 759-767



Human endometrial stromal cell cultures, stimulated for two days with recombinant transforming growth factor beta1 (TGFbeta1; 10 ng/ml), contained conditioned medium concentrations of urokinase plasminogen activator (uPA), plasminogen activator inhibitor 1 (PAI1), and uPA:PAI1 complex. Since a number of cellular effects have been reported to follow a binding of enzymatically inactive uPA to the receptor in different cell types, we studied the influence of uPA:PAI1 complex on human umbilical vein endothelial cells (HUVEC) and human microvascular endothelial cells (HMEC-1). Increasing concentrations of uPA:PAI1 complex as well as free uPA resulted in a dose-dependent stimulation of endothelial cell migration. Stimulation by the complex was of the same magnitude as that of free uPA on a molar basis and reached its maximum at 1 nM in both cell types. PAI1 by itself, however, had no effect on cell migration. The migratory response to both uPA and the uPA:PAI1 complex was inhibited by antibody adhesion to the cell surface receptor for uPA. In addition, we found that TGFbeta1 had a direct stimulatory effect on migration in both HUVEC and HMEC-1. This response did not, however, involve the binding of uPA to the uPA receptor. Since TGFbetas are expressed in endometrial tissue and reportedly stimulate angiogenesis in other tissues in vivo, though not endothelial cell proliferation in vitro, they may engage in the regeneration of endometrial vasculature indirectly via perivascular cells. We found that the uPA:PAII complex, when released from endometrial stromal cells in response to TGFbeta1, stimulated endothelial cell migration. This suggests a possible mechanism for paracrine stimulation of endometrial angiogenesis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008787464

Download citation: RISBibTeXText

PMID: 9746723


Related references

Human Endothelial Cell Migration Is Stimulated by Urokinase Plasminogen Activator:Plasminogen Activator Inhibitor 1 Complex Released from Endometrial Stromal Cells Stimulated with Transforming Growth Factor 1; Possible Mechanism for Paracrine Stimulation of Endometrial Angiogenesis. Biology of Reproduction 59(4): 759-767, 1998

A novel mechanism for paracrine stimulation of endometrial angiogenesis Urokinase plasminogen activator /plasminogen activator inhibitor-1 complex, released from stromal cells stimulated with TGF-beta-1, stimulates endothelial cells migration. Fibrinolysis 10(Suppl. 3): 117, 1996

Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor , and is mediated via the urokinase plasminogen activator receptor. Fibrinolysis & Proteolysis 14(Suppl. 1): 21, 2000

Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor. Journal of Clinical Endocrinology and Metabolism 86(4): 1724-1730, 2001

Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells. Fertility and Sterility 83(Suppl. 1): 1155-1160, 2005

Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells. Journal of Clinical Endocrinology and Metabolism 86(3): 1332-1340, 2001

Progesterone stimulates internalization and degradation of urokinase plasminogen activator by upregulating the expression of plasminogen activator inhibitor 1 and the urokinase receptor in endometrial stromal cells Comparison of progesterone and TGF-beta. Fibrinolysis 8(Suppl. 1): 58, 1994

The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis. Zhonghua Gan Zang Bing Za Zhi 12(7): 400-402, 2004

Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa. Head & Neck 23(9): 725-732, 2001

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76(6): 998-1005, 1995

Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells. British Journal of Cancer 77(3): 396-403, 1998

Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas. Gynecologic Oncology 79(2): 244-250, 2000

Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1. Journal of Clinical Endocrinology and Metabolism 80(8): 2504-2510, 1995

Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. Thrombosis and Haemostasis 84(1): 59-64, 2000

Urokinase-type-plasminogen-activator production by human breast fibroblasts in vitro Influence of transforming growth factor-beta1 compared with factor released by human epithelial-carcinoma cells. International Journal of Cancer 76(6): 829-835, 1998